DLBCL patients treated with CD19 CAR T cells experience a...

Blood Advances 2020 / 07 Vol. 4; Iss. 13

DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality

Wudhikarn, Kitsada, Pennisi, Martina, Garcia-Recio, Marta, Flynn, Jessica R., Afuye, Aishat, Silverberg, Mari Lynne, Maloy, Molly A., Devlin, Sean M., Batlevi, Connie Lee, Shah, Gunjan L., Scordo, Mic
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2020001972
Date:
July, 2020
File:
PDF, 1.00 MB
2020
Conversion to is in progress
Conversion to is failed